aldehyde dehydrogenase 2 family member
| GO Term | Evidence Code | PMID |
|---|---|---|
| liver development | ||
| response to ischemia | ||
| ethanol metabolic process | ||
| ethanol catabolic process | ||
| acetaldehyde metabolic process |
| GO Term | Evidence Code | PMID |
|---|---|---|
| mitochondrion | ||
| mitochondrial matrix |
| GO Term | Evidence Code | PMID |
|---|---|---|
| aldehyde dehydrogenase (NAD+) activity | ||
| aldehyde dehydrogenase (NAD+) activity | ||
| aldehyde dehydrogenase (NAD+) activity | ||
| aldehyde dehydrogenase (NAD+) activity | ||
| protein binding |
| Gene Ontology |
|---|
| oxidoreductase activity, acting on the aldehyde or oxo group of donors, NAD or NADP as acceptor |
| oxidoreductase activity |
| Location | References |
|---|---|
| DO ID | Disease Name | Source |
|---|---|---|
| DOID:0070508 | metabolic dysfunction and alcohol associated liver disease |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.4.0
Last updated: December 8, 2025